MedTrace Logo

Effect of the Dry Needling and Kinesio Taping in Management of Mechanical Low Back Pain

NCT04976582 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-07-26

No results posted yet for this study

Summary

Low back pain (LBP) is an extremely common problem that most people experience at some point in their life. It is the leading cause of activity limitation and work absence throughout much of the world. In India, occurrence of LBP is also alarming. Nearly 60% of the population has significant back pain at some time in their life. In Brazil, spinal pain (cervical, thoracic and lumbar) was considered the second most prevalent complaint, affecting approximately 13.5% of the population. It is estimated that globally 39% of the population will have at least one episode of back pain throughout their lives. In episodes of pain greater than 12 weeks (classified as chronic lower back pain), the prognosis is unfavorable and is highly associated with high treatment costs and work absenteeism.

Non-specific low back pain" \[NSLBP\] is defined as, low back pain that is not attributable to a recognizable or known specific pathology - bone disorder in the spine \[fracture\], radicular nerve compression, slipped intervertebral disk, stenosis in lumbar spine, inflammatory disorder of spine \[ankylosing spondylitis\], cauda equine syndrome, congenital back disorder, infection in the spine \[discitis\], tumour in lumbar area, osteoporosis, meningitis, Cancer, HIV, autoimmune disorder \[RA\].

Conditions

  • Mechanical Low Back Pain

Interventions

DEVICE

dry needle

modalities including transcutaneous electrical nerve stimulation (TENS); electrical muscle stimulation (EMS); and interferential current (IFC). Physical agents including ultrasound, hot packs, and cold packs. Exercise including McKenzie exercises) will be administered.

Sponsors & Collaborators

  • Shaheed Zulfiqar Ali Bhutto Medical University

    lead OTHER

Principal Investigators

  • Adeela Asad, m.phil · Rawal Institue of Health Sciences Islamabad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-31
Primary Completion
2021-08-31
Completion
2021-09-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04976582 on ClinicalTrials.gov